Results 271 to 280 of about 292,778 (314)
Some of the next articles are maybe not open access.

Head and neck cancer

Nursing Standard, 2017
Essential facts Head and neck cancers include those of the mouth and throat, and rarer forms affecting the sinuses, salivary glands, nose or middle ear. The Oracle Cancer Trust says head and neck cancer is the UKs sixth most common type, with 31 people diagnosed each day.
openaire   +3 more sources

Head and Neck Cancer

New England Journal of Medicine, 2001
Head and neck cancers include neoplasms of the oral cavity, pharynx, and larynx. The risk of these cancers is strongly associated with smoking and alcohol ingestion. There have been important advances in understanding of the molecular pathogenesis and progression of head and neck cancer and also in approaches to therapy, which include innovations in ...
Arlene A. Forastiere   +3 more
openaire   +3 more sources

CANCER OF THE HEAD AND NECK

Annals of Internal Medicine, 1958
Excerpt Since the internist may be the first physician to see a patient, he should be thoroughly familiar with the problems of head and neck cancer.
openaire   +3 more sources

Head and Neck Cancers [PDF]

open access: possible, 2010
Head and neck cancers constitute approximately 10% of all cancers [1]. They are named according their location and subsite in the head or neck. Head and neck cancers are essentially seen in older patients (50–70 years), but they can also be seen in children, and they are more common in males than females.
Gokhan Ozyigit   +2 more
openaire   +1 more source

Head and neck cancer

Cancer and Metastasis Reviews, 2003
In this review, the authors outline the epidemiology, genetic factors, treatment and outcomes of head and neck cancer.
Steve, McMahon, Amy Y, Chen
openaire   +2 more sources

The chemotherapy of head and neck cancer

Anti-Cancer Drugs, 1999
Studies of combination therapy [with agents such as cisplatin, 5-fluorouracil (5-FU) and methotrexate] have shown some improvements in response rate; however, no obvious survival advantage over monotherapy in the treatment of patients with metastatic or advanced locoregional cancer of the head and neck have been observed.
openaire   +6 more sources

Taxanes In Head and Neck Cancer

Future Oncology, 2005
Paclitaxel and docetaxel are cytotoxic agents that act on the microtubule system and cause cell death. They are active in patients with squamous cell carcinoma of the head and neck region. They can be combined with other cytotoxic agents and radiotherapy with acceptable toxicity.
Schrijvers, Dirk, Vermorken, Jan Baptist
openaire   +4 more sources

Head and neck cancer

Emergency Nurse, 2016
A diagnosis of head and neck cancer can be physically and emotionally debilitating. The condition and its treatment can affect breathing, eating and communicating, and change physical appearance. Head and neck cancer can have profound effects on psychological and psychosocial well-being and subsequent quality of life.
openaire   +2 more sources

Immunotherapy for Head and Neck Cancer

Oral and Maxillofacial Surgery Clinics of North America, 2019
The immune system has a vital role in the development, establishment, and progression of head and neck squamous cell carcinoma (HNSCC). Immune evasion of cancer cells leads to progression of HNSCC. An understanding of this mechanism provides the basis for improved therapies and outcomes for patients.
Rom Leidner, Felix Sim, R.B. Bell
openaire   +5 more sources

Head and Neck Cancers

Primary Care: Clinics in Office Practice
Head and neck cancers are heterogenous cancers with rising incidence of treatable/curative cancers. They are treated comprehensively by multidisciplinary teams. Survivors of head and neck cancers often deal with the sequalae of therapy and with increasing survival rates, it is anticipated that the primary care physicians are going to encounter more ...
Archana, Kudrimoti, Mahesh R, Kudrimoti
openaire   +2 more sources

Home - About - Disclaimer - Privacy